HLA-DRB5 and coccidioidomycosis: For HLA-DRB5, several drugs have been identified, including 1D09C3 for various forms of cancer, Coccidioides immitis spherule for detecting delayed-type hypersensitivity in individuals with a history of pulmonary coccidioidomycosis, and Apolizumab for solid tumors/cancer.